Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2005 1
2007 3
2008 3
2010 2
2011 1
2012 1
2013 1
2014 8
2015 4
2016 6
2017 1
2018 4
2019 4
2020 2
2021 4
2023 4
2024 4
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Calprotectin in inflammatory bowel disease.
Khaki-Khatibi F, Qujeq D, Kashifard M, Moein S, Maniati M, Vaghari-Tabari M. Khaki-Khatibi F, et al. Clin Chim Acta. 2020 Nov;510:556-565. doi: 10.1016/j.cca.2020.08.025. Epub 2020 Aug 18. Clin Chim Acta. 2020. PMID: 32818491 Free PMC article. Review.
Performing colonoscopy and histopathologic evaluation on an inflamed bowel biopsy specimen are currently considered as gold standards for diagnosis and management of IBD. Correspondingly, these techniques are known to be invasive and costly. In recent decades, fecal cal …
Performing colonoscopy and histopathologic evaluation on an inflamed bowel biopsy specimen are currently considered as gold standards for di …
Faecal Calprotectin.
Pathirana WGW, Chubb SP, Gillett MJ, Vasikaran SD. Pathirana WGW, et al. Clin Biochem Rev. 2018 Aug;39(3):77-90. Clin Biochem Rev. 2018. PMID: 30828114 Free PMC article. Review.
Faecal calprotectin is a very sensitive marker for inflammation in the gastrointestinal tract, and useful for the differentiation of inflammatory bowel disease (IBD) from irritable bowel syndrome (IBS). Faecal calprotectin is used for the diagno …
Faecal calprotectin is a very sensitive marker for inflammation in the gastrointestinal tract, and useful for the differentiation …
Comparison of Fecal Calprotectin with Different Endoscopic Scores in the Assessment of Ulcerative Colitis (UC) Activity and Its Utility in Differentiating IBS from IBD.
Acharya K, Bhardwaj V, Chuahan I, Mushfiq S, Bhatt S, Lamba BM. Acharya K, et al. Euroasian J Hepatogastroenterol. 2023 Jul-Dec;13(2):120-123. doi: 10.5005/jp-journals-10018-1411. Euroasian J Hepatogastroenterol. 2023. PMID: 38222953 Free PMC article.
AIM: To evaluate the usefulness of fecal calprotectin as a biomarker for disease activity in UC, its correlation with disease extent and its utility in differentiating IBS from IBD. ...HOW TO CITE THIS ARTICLE: Acharya K, Bhardwaj V, Chuahan I, et al. …
AIM: To evaluate the usefulness of fecal calprotectin as a biomarker for disease activity in UC, its correlation with disease extent …
Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation.
Fu Y, Wang L, Xie C, Zou K, Tu L, Yan W, Hou X. Fu Y, et al. Sci Rep. 2017 Jun 1;7(1):2669. doi: 10.1038/s41598-017-02835-5. Sci Rep. 2017. PMID: 28572616 Free PMC article.
Recently we identified an excellent new biomarker B cell-activating factor (BAFF) for IBD. Here in this study we compared the efficacy of faecal BAFF, calprotectin and FOBT to find the "best non-invasive marker". Results showed that for discriminating IBD …
Recently we identified an excellent new biomarker B cell-activating factor (BAFF) for IBD. Here in this study we compared the …
Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies.
Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Schoepfer AM, et al. Inflamm Bowel Dis. 2008 Jan;14(1):32-9. doi: 10.1002/ibd.20275. Inflamm Bowel Dis. 2008. PMID: 17924558
BACKGROUND: Symptoms of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) can overlap. We aimed to determine the accuracy of fecal markers, C-reactive protein (CRP), blood leukocytes, and antibody panels for discriminating IBD from IBS …
BACKGROUND: Symptoms of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) can overlap. We aimed to determine …
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.
Däbritz J, Musci J, Foell D. Däbritz J, et al. World J Gastroenterol. 2014 Jan 14;20(2):363-75. doi: 10.3748/wjg.v20.i2.363. World J Gastroenterol. 2014. PMID: 24574706 Free PMC article. Review.
Phagocyte-specific proteins of the S100 family (S100A12, calprotectin) are amongst the most promising faecal biomarkers of inflammation. Faecal leukocyte degranulation markers (lactoferrin, polymorphonuclear elastase and myeloperoxidase) have also been suggested as …
Phagocyte-specific proteins of the S100 family (S100A12, calprotectin) are amongst the most promising faecal biomarkers of inflammati …
A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.
Menees SB, Powell C, Kurlander J, Goel A, Chey WD. Menees SB, et al. Am J Gastroenterol. 2015 Mar;110(3):444-54. doi: 10.1038/ajg.2015.6. Epub 2015 Mar 3. Am J Gastroenterol. 2015. PMID: 25732419
None of the biomarkers reliably distinguished between IBS and healthy controls. At a CRP level of 0.5 or calprotectin level of 40 mug/g, there was a 1% probability of having IBD. Individual analysis of ESR and lactoferrin had little clinical utility. CONCL …
None of the biomarkers reliably distinguished between IBS and healthy controls. At a CRP level of 0.5 or calprotectin level o …
Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy.
Long MD, Drossman DA. Long MD, et al. Am J Gastroenterol. 2010 Aug;105(8):1796-8. doi: 10.1038/ajg.2010.162. Am J Gastroenterol. 2010. PMID: 20686466
These patients may be considered to have an overlap of IBD and irritable bowel syndrome (IBD-IBS). In this month's Journal, a proposal is made that continued symptoms in patients with elevated calprotectin, a marker of inflammation, is related to IB …
These patients may be considered to have an overlap of IBD and irritable bowel syndrome (IBD-IBS). In this month's Jour …
Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran.
Sharbatdaran M, Holaku A, Kashifard M, Bijani A, Firozjahi A, Hosseini A, Siadati S. Sharbatdaran M, et al. Caspian J Intern Med. 2018 Winter;9(1):60-64. Caspian J Intern Med. 2018. PMID: 29387321 Free PMC article.
The first group included patients with confirmed IBD and the second group included patients with diseases other than IBD, patients with IBS and healthy persons. ...CONCLUSIONS: The results pointed to this fact that fecal calprotectin can be a noninvasi …
The first group included patients with confirmed IBD and the second group included patients with diseases other than IBD, pati …
Clinical Significance of Faecal Calprotectin in Differentiating Inflammatory Bowel Disease from Irritable Bowel Syndrome.
Chowdhury MFK, Ghosh CK, Miah MSA, Uddin MA, Rassell M, Rashid MH, Pal AK, Mahabub-Uz-Zaman K, Saha KP, Miah MAR. Chowdhury MFK, et al. Mymensingh Med J. 2024 Oct;33(4):1149-1156. Mymensingh Med J. 2024. PMID: 39351737
There was a significant difference of faecal calprotectin level between IBD and IBS patients (p-value <0.001). The sensitivity and specificity of faecal calprotectin to differentiate IBD from IBS was 91.1% and 86.7% respectively …
There was a significant difference of faecal calprotectin level between IBD and IBS patients (p-value <0.001). The s …
53 results